These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 2502615)
1. Mupirocin: a new topical therapy for impetigo. Putnam CD; Reynolds MS J Pediatr Health Care; 1989; 3(4):224-7. PubMed ID: 2502615 [TBL] [Abstract][Full Text] [Related]
2. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy. Mertz PM; Marshall DA; Eaglstein WH; Piovanetti Y; Montalvo J Arch Dermatol; 1989 Aug; 125(8):1069-73. PubMed ID: 2502950 [TBL] [Abstract][Full Text] [Related]
8. Mupirocin: a topical antibiotic with a unique structure and mechanism of action. Parenti MA; Hatfield SM; Leyden JJ Clin Pharm; 1987 Oct; 6(10):761-70. PubMed ID: 3146455 [TBL] [Abstract][Full Text] [Related]
9. Mupirocin--a new topical antibiotic. Med Lett Drugs Ther; 1988 May; 30(766):55-6. PubMed ID: 3129636 [No Abstract] [Full Text] [Related]
10. Mupirocin in the treatment of impetigo. Infectious Diseases and Immunization Committee, Canadian Paediatric Society. CMAJ; 1990 Mar; 142(6):543-4. PubMed ID: 2107019 [No Abstract] [Full Text] [Related]
11. Topical mupirocin vs. systemic erythromycin treatment for pyoderma. McLinn S Pediatr Infect Dis J; 1988 Nov; 7(11):785-90. PubMed ID: 3148127 [TBL] [Abstract][Full Text] [Related]
12. Topical mupirocin in the treatment of bacterial skin infections. Rumsfield J; West DP; Aronson IK Drug Intell Clin Pharm; 1986 Dec; 20(12):943-8. PubMed ID: 3102197 [TBL] [Abstract][Full Text] [Related]
13. The clinical development of mupirocin. Pappa KA J Am Acad Dermatol; 1990 May; 22(5 Pt 1):873-9. PubMed ID: 2112164 [TBL] [Abstract][Full Text] [Related]
14. Interventions for impetigo. Koning S; Verhagen AP; van Suijlekom-Smit LW; Morris A; Butler CC; van der Wouden JC Cochrane Database Syst Rev; 2004; (2):CD003261. PubMed ID: 15106198 [TBL] [Abstract][Full Text] [Related]
15. Mupirocin (2 percent) ointment in the treatment of primary and secondary skin infections. Odom RB Cutis; 1989 Jun; 43(6):599-601. PubMed ID: 2501071 [TBL] [Abstract][Full Text] [Related]
16. Comparison of oral cephalexin, topical mupirocin and topical bacitracin for treatment of impetigo. Bass JW; Chan DS; Creamer KM; Thompson MW; Malone FJ; Becker TM; Marks SN Pediatr Infect Dis J; 1997 Jul; 16(7):708-10. PubMed ID: 9239775 [No Abstract] [Full Text] [Related]
17. Comparison of mupirocin and erythromycin in the treatment of impetigo. Britton JW; Fajardo JE; Krafte-Jacobs B J Pediatr; 1990 Nov; 117(5):827-9. PubMed ID: 2121951 [No Abstract] [Full Text] [Related]
19. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections. Gisby J; Bryant J Antimicrob Agents Chemother; 2000 Feb; 44(2):255-60. PubMed ID: 10639346 [TBL] [Abstract][Full Text] [Related]
20. A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice. Villiger JW; Robertson WD; Kanji K; Ah Chan M; Fetherston J; Hague IK; Haycock D; Hunter P Curr Med Res Opin; 1986; 10(5):339-45. PubMed ID: 3102167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]